Elevance Health, Inc.
ELV
$547.71
$3.820.70%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -0.26% | 4.84% | 4.87% | 10.60% | 9.38% |
| Total Other Revenue | 8.43% | 18.03% | 21.40% | 28.83% | 19.54% |
| Total Revenue | 0.96% | 6.80% | 7.29% | 13.05% | 10.70% |
| Cost of Revenue | -0.78% | 3.77% | 4.03% | 9.76% | 9.05% |
| Gross Profit | 5.66% | 16.17% | 16.40% | 22.68% | 15.43% |
| SG&A Expenses | 5.19% | 6.34% | 18.04% | 24.57% | 14.57% |
| Depreciation & Amortization | -50.64% | -12.15% | -5.78% | 33.13% | 82.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.18% | 4.21% | 6.93% | 12.86% | 10.44% |
| Operating Income | 11.64% | 82.54% | 12.95% | 15.97% | 14.48% |
| Income Before Tax | 12.22% | -4.21% | -22.24% | 15.03% | 13.57% |
| Income Tax Expenses | 12.20% | 1.19% | -33.08% | 19.88% | 16.70% |
| Earnings from Continuing Operations | 12.23% | -5.25% | -18.65% | 13.59% | 12.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 80.00% | 308.33% | -320.00% | -200.00% | -250.00% |
| Net Income | 12.92% | -1.04% | -19.59% | 13.19% | 11.18% |
| EBIT | 11.64% | 82.54% | 12.95% | 15.97% | 14.48% |
| EBITDA | 6.09% | 57.99% | 9.96% | 15.13% | 16.30% |
| EPS Basic | 15.25% | 1.23% | -18.12% | 15.16% | 13.01% |
| Normalized Basic EPS | 15.41% | 109.91% | 12.86% | 16.53% | 13.59% |
| EPS Diluted | 15.54% | 1.22% | -17.67% | 15.75% | 13.39% |
| Normalized Diluted EPS | 15.73% | 109.91% | 13.51% | 17.25% | 13.95% |
| Average Basic Shares Outstanding | -2.02% | -2.24% | -1.79% | -1.70% | -1.62% |
| Average Diluted Shares Outstanding | -2.29% | -2.24% | -2.35% | -2.30% | -1.92% |
| Dividend Per Share | 10.14% | 15.63% | 15.63% | 15.63% | 15.63% |
| Payout Ratio | -0.04% | 0.15% | 0.41% | 0.00% | 0.02% |
